These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 23795222)

  • 41. Herbal nanomedicines: Recent advancements, challenges, opportunities and regulatory overview.
    Teja PK; Mithiya J; Kate AS; Bairwa K; Chauthe SK
    Phytomedicine; 2022 Feb; 96():153890. PubMed ID: 35026510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure.
    Khan AU; Khan M; Cho MH; Khan MM
    Bioprocess Biosyst Eng; 2020 Aug; 43(8):1339-1357. PubMed ID: 32193755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
    Tyagi P; Subramony JA
    J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
    Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
    J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanoparticles in pregnancy: the next frontier in reproductive therapeutics.
    Pritchard N; Kaitu'u-Lino T; Harris L; Tong S; Hannan N
    Hum Reprod Update; 2021 Feb; 27(2):280-304. PubMed ID: 33279994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of nanotechnology in drug delivery systems for respiratory diseases (Review).
    Luo MX; Hua S; Shang QY
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antioxidant nanoparticles for control of infectious disease.
    Elswaifi SF; Palmieri JR; Hockey KS; Rzigalinski BA
    Infect Disord Drug Targets; 2009 Aug; 9(4):445-52. PubMed ID: 19689385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Green nanomedicine: the path to the next generation of nanomaterials for diagnosing brain tumors and therapeutics?
    Mostafavi E; Medina-Cruz D; Vernet-Crua A; Chen J; Cholula-Díaz JL; Guisbiers G; Webster TJ
    Expert Opin Drug Deliv; 2021 Jun; 18(6):715-736. PubMed ID: 33332168
    [No Abstract]   [Full Text] [Related]  

  • 50. Nanotechnology in pulmonary medicine.
    Doroudian M; O' Neill A; Mac Loughlin R; Prina-Mello A; Volkov Y; Donnelly SC
    Curr Opin Pharmacol; 2021 Feb; 56():85-92. PubMed ID: 33341460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nano Phytomedicine Based Delivery System for CNS Disease.
    Jahangir MA; Anand C; Muheem A; Gilani SJ; Taleuzzaman M; Zafar A; Jafar M; Verma S; Barkat MA
    Curr Drug Metab; 2020; 21(9):661-673. PubMed ID: 32445453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanotherapeutics for the Treatment of Cancer and Arthritis.
    Patel P; Meghani N; Kansara K; Kumar A
    Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic and Therapeutic Nanomedicine.
    Joo J
    Adv Exp Med Biol; 2021; 1310():401-447. PubMed ID: 33834444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunomodulation in age-related disorders and nanotechnology interventions.
    Chintapula U; Chikate T; Sahoo D; Kieu A; Guerrero Rodriguez ID; Nguyen KT; Trott D
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1840. PubMed ID: 35950266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanotechnology platforms for cancer immunotherapy.
    Yang Z; Ma Y; Zhao H; Yuan Y; Kim BYS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1590. PubMed ID: 31696664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nanomedicine: An effective tool in cancer therapy.
    Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
    Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medicinal Herbs: Promising Immunomodulators for the Treatment of Infectious Diseases.
    Alanazi HH; Elasbali AM; Alanazi MK; El Azab EF
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Integration of Nanomedicine with Traditional Chinese Medicine: Drug Delivery of Natural Products and Other Opportunities.
    Zeng M; Guo D; Fernández-Varo G; Zhang X; Fu S; Ju S; Yang H; Liu X; Wang YC; Zeng Y; Casals G; Casals E
    Mol Pharm; 2023 Feb; 20(2):886-904. PubMed ID: 36563052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
    Patel P; Shah J
    Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.